Hyponatremia, convulsions and neuroleptic malignant syndrome in a male with schizoaffective disorder

Reference

• Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. American Journal of Psychiatry 1988; 145: 675–683
   PubMed Web of Science ®Google Scholar
• Loudon JB. Drug treatments. Companion to psychiatric studies. 5th edition. Edinburgh: Churchill Livingstone, RE Kendell, AK Zealley, 1993; 817–847
   Google Scholar
• Cattell WR. Water, electrolyte and acid-base homeostasis. Clinical medicine. 2nd edition. London: Balliere-Tindall, PJ Kumar, ML Clark, 1990; 490–511
   Google Scholar
• Singh S, Padi MH, Bullard H, Freeman H. Water intoxication in psychiatric patients. British Journal of Psychiatry 1985; 146: 127–131
   PubMed Web of Science ®Google Scholar
• Goldman MB. A rational approach to disorders of water balance in psychiatric patients. Hospital and Community Psychiatry 1991; 42: 488–494
   PubMedGoogle Scholar
• Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. New England Journal of Medicine 1988; 318: 387–403
   PubMedGoogle Scholar
• Oh MS, Carroll HJ. Disorders of sodium metabolism: hyper-natremia and hyponatremia. Critical Care Medicine 1992; 20: 94–103
   PubMedGoogle Scholar
• Arieff AI. Management of hyponatremia. British Medical Journal 1993; 307: 305–308
   PubMed Web of Science ®Google Scholar
• Caroff SN, Mann SC. Neuroleptic malignant syndrome. Medical Clinics of North America 1993; 77: 185–202
   PubMed Web of Science ®Google Scholar
• Reilly JJ, Crowe SF, Lloyd JH. Neuroleptic toxicity syndromes: a clinical spectrum. Australian and New Zealand Journal of Psychiatry 1991; 25: 499–505
   PubMed Web of Science ®Google Scholar
• Heiman-Patterson TD. Neuroleptic malignant syndrome and malignant hyperthermia. Medical Clinics of North America 1993; 77: 477–492
   PubMedGoogle Scholar
• Rosenberg MR, Green M. Neuroleptic malignant syndrome -review of response to therapy. Archives of Internal Medicine 1989; 149: 1927–1931
   PubMedGoogle Scholar
• Guze BH, Baxter LR. Neuroleptic malignant syndrome. New England Journal of Medicine 1985; 313: 163–166
   PubMed Web of Science ®Google Scholar
• Levenson JL. Neuroleptic malignant syndrome. American Journal of Psychiatry 1985; 142: 1137–1145
   PubMed Web of Science ®Google Scholar
• Caroff SN. Neuroleptic malignant syndrome. Journal of Clinical Psychiatry 1980; 41: 79–83
   PubMed Web of Science ®Google Scholar
• Tomiyama J, Kametani H, Kumagai Y, Adachi Y, Tohri K. Water intoxication and rhabdomyolysis. Japanese Journal of Medicine 1990; 29: 52–55
   PubMedGoogle Scholar
• O'Dwyer A, Sheppard NP. The role of creatine kinase in neuroleptic malignant syndrome. Psychological Medicine 1993; 23: 323–326
   PubMedGoogle Scholar
• Adityanjee. The myth of elevated serum creatine phosphokinase level in neuroleptic malignant syndrome. British Journal of Psychiatry 1991; 158: 706–707
   PubMedGoogle Scholar
• Cheng JC, Zikos D. Skopicki HA, Peterson DR, Fisher KA. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction. American Journal of Medicine 1990; 88: 561–566
   Google Scholar
• Kaplan HI, Sadock BJ. Biological therapies. In: Synopsis of psychiatry. 6th edition. Baltimore: Williams and Wilkins,. 1991; 606–677
   Google Scholar
• Rosebush PI, Stewart TD, Gelenburg AJ. Twenty neuroleptic re-challenges after neuroleptic malignant syndrome in 15 patients. Journal of Clinical Psychiatry 1989; 50: 295–298
   PubMed Web of Science ®Google Scholar
• Garcia-Escrig M, Bermejo-Pareja F, Soto-Tellez O, Diaz-Guzman J, Lledo A. Sindrome neuroleptico maligno asociado a sindrome de inadecuada secrecion de hormona antidiuretica. Archives of Neurobiology of Madrid 1992; 55: 75–78
   PubMedGoogle Scholar
• Tormey WP, Cronin T, Devlin JD. Hyponatremia masquerading as malignant neuroleptic syndrome. British Journal of Psychiatry 1987; 150: 412
   PubMedGoogle Scholar
• Gibb WR, Wedzicha JA, Hoffbrand BI. Recurrent neuroleptic malignant syndrome and hyponatremia. Journal of Neurology, Neurosurgery and Psychiatry 1986; 49: 960–961
   PubMedGoogle Scholar
• Adityanjee. Recurrence, hyponatremia and neuroleptic malignant syndrome. Journal of Neurology, Neurosurgery and Psychiatry 1987; 50: 504–505
   PubMedGoogle Scholar
• Tomson CR. Neuroleptic malignant syndrome associated with inappropriate antidiuresis and psychogenic polydipsia. British Medical Journal. 1986, 292:171
   Google Scholar
• WedzeichaJA Hoffbrand BI. Neuroleptic malignant syndrome and hyponatremia. Lancet 1984; i: 963
   Google Scholar
• Michel K, Kolanowska T. A survey of prescribing psychotropic drugs in two psychiatric hospitals. British Journal of Psychiatry 1981; 138: 217–221
   PubMed Web of Science ®Google Scholar
• Muijen M, Silverstone T. A comparative hospital survey of psychotropic drug. British Journal of Psychiatry 1987; 144: 501–504
   Google Scholar
• Diamond H, Tislow R, Snyder T, Richels K. Peer review of prescribing patterns in CHMC. American Journal of Psychiatry 1976; 133: 697–699
   PubMedGoogle Scholar
• Khanna R, Bhandari SN, Das A. Survey of psychotropic drug prescribing pattern for long stay patients. Indian Journal of Psychiatry 1990; 32: 162–165
   PubMedGoogle Scholar
• Kendell RE. The role of diagnosis in psychiatry. Oxford: Black-well,. 1975
   Google Scholar